Skip to main content
MedPacto, Inc. logo

MedPacto, Inc. — Investor Relations & Filings

Ticker · 235980 ISIN · KR7235980000 KO Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2020-10-13 Report Publication Anno…
Country KR South Korea
Listing KO 235980

About MedPacto, Inc.

http://www.medpacto.com/eng/

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 1,000 characters) notifying the public about an upcoming Investor Relations (IR) event (Corporate Day). It provides the date, time, location, and purpose of the meeting, and mentions that the actual IR materials will be available on the KRX KIND system on the day of the event. Per the 'Menu vs Meal' rule, this is an announcement of an event/report rather than the presentation itself, and it fits the definition of a Report Publication Announcement (RPA) or a general regulatory filing regarding corporate activities.
2020-10-13 Korean
기타경영사항(특허권취득)(자율공시)(신규한 피리미딘화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암 및 염증질환의 예방 또는 치료용 약학적 조성물)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) by MedPacto regarding the acquisition of a patent for a new pyrimidine compound used in cancer and inflammatory disease treatment. It details the patent name, content, and utilization plan. Since it is a regulatory announcement regarding a specific corporate event (patent acquisition) that does not fit into financial reporting or other specific categories, it is classified as a general regulatory filing.
2020-09-01 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the granting of stock options (주식매수선택권 부여에 관한 신고). This type of disclosure, which details the issuance of stock options to employees and executives, falls under the category of capital changes or share-related announcements. Since it specifically details the granting of stock options rather than a general share issue or a transaction in own shares, and given the specific regulatory nature of the filing in the Korean market, it is best classified as a Regulatory Filing (RNS) as it serves as a formal disclosure of a corporate action.
2020-08-14 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for MedPacto, Inc. for the period ending June 30, 2020. It contains comprehensive financial statements, management discussion, and business information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-13 Korean
투자판단관련주요경영사항(비소세포폐암 1차 치료제로 백토서팁 + 키트루다 병용 임상2상 시험계획(IND) 식품의약품안전처(MFDS) 승인)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korean Exchange (KRX) system, specifically a 'Major Management Matter' disclosure regarding the approval of a Phase 2 clinical trial (IND) by the Ministry of Food and Drug Safety. Since it does not fit into specific categories like financial reports, dividends, or board changes, and is a standard regulatory disclosure of a material business event, it is classified as a Regulatory Filing (RNS).
2020-08-07 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. It also mentions that the actual IR presentation materials will be distributed at the event or made available on the KRX KIND system. Since this is an announcement of an event and the availability of materials rather than the presentation itself, it falls under the Report Publication Announcement (RPA) category.
2020-07-20 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.